{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:12:58Z","timestamp":1790730778481,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1245\/s10434-020-08580-w","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T15:04:01Z","timestamp":1592233441000},"page":"3330-3338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma"],"prefix":"10.1245","volume":"27","author":[{"given":"Kate","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"8580_CR1","volume-title":"Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology","author":"HA Edmondsun","year":"1958","unstructured":"Edmondsun HA. Tumors of the liver and intrahepatic bile ducts. Atlas tumor pathology, Washington: Armed Forces Institute of Pathology; 1958."},{"key":"8580_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","volume":"242","author":"JB Rooks","year":"1979","unstructured":"Rooks JB, Ory HW, Ischak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644\u20138.","journal-title":"JAMA."},{"key":"8580_CR3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(73)92594-4","volume":"2","author":"JK Baum","year":"1973","unstructured":"Baum JK, Bookstein JJ, Holz F, et al. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973;2:926-9.","journal-title":"Lancet."},{"issue":"2","key":"8580_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-86-2-180","volume":"86","author":"HA Edmondson","year":"1977","unstructured":"Edmondson HA, Reynold TB, Henderson B, et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med. 1977;86(2):180\u20132.","journal-title":"Ann Intern Med."},{"key":"8580_CR5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","volume":"152","author":"JC Nault","year":"2017","unstructured":"Nault JC, Couchy G, Balabaud C, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology. 2017;152:880\u201394.","journal-title":"Gastroenterology."},{"issue":"12","key":"8580_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrgastro.2014.151","volume":"11","author":"J Belghiti","year":"2014","unstructured":"Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11(12):737\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"8580_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.21684","volume":"46","author":"V Paradis","year":"2007","unstructured":"Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology. 2007;46(1):140\u20136.","journal-title":"Hepatology."},{"key":"8580_CR8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2036.2011.04772.x","volume":"34","author":"C Bunchorntavakul","year":"2011","unstructured":"Bunchorntavakul C, Bahirwani R, Drazek D, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011;34:664\u201374.","journal-title":"Aliment Pharmacol Ther."},{"key":"8580_CR9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MEG.0b013e3282f824e9","volume":"20","author":"V Ozenne","year":"2008","unstructured":"Ozenne V, Paradis V, Vullierme MP, Vilgrain V, Leblanc T, Belghiti J. Liver tumours in patients with Fanconi anaemia: a report of three cases. Eur J Gastroenterol Hepatol. 2008;20:1036\u20139.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"8","key":"8580_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","volume":"32","author":"P Biouac-Sage","year":"2012","unstructured":"Biouac-Sage P, Taouji S, Possenti L, et al. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32(8):1217\u201321.","journal-title":"Liver Int."},{"key":"8580_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.","journal-title":"Cell."},{"key":"8580_CR12","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cncr.24687","volume":"115","author":"AB Siegel","year":"2009","unstructured":"Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115:5651\u201361.","journal-title":"Cancer."},{"issue":"5","key":"8580_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","volume":"26","author":"C Pilati","year":"2015","unstructured":"Pilati C, Zuckman-Rossi J. Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway. Cytokine Growth Factor Rev. 2015;26(5):499\u2013506.","journal-title":"Cytokine Growth Factor Rev"},{"key":"8580_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","volume":"24","author":"P Labrune","year":"1997","unstructured":"Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997;24:276\u201379.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8580_CR15","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1111\/j.1365-2559.2011.04153.x","volume":"60","author":"S Sakellariou","year":"2012","unstructured":"Sakellariou S, Al-Hussaini H, Scalori A, et al. Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. Histopathology. 2012;60:E58\u201365.","journal-title":"Histopathology."},{"issue":"6","key":"8580_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pathol.2018.05.003","volume":"50","author":"G Miller","year":"2018","unstructured":"Miller, G. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria. Pathology. 2018;50(6):593\u20139.","journal-title":"Pathology."},{"key":"8580_CR17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Biolac-Sage","year":"2007","unstructured":"Biolac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740\u20138.","journal-title":"Hepatology."},{"key":"8580_CR18","first-page":"198","volume-title":"WHO classification of tumours of the digestive system","author":"P Bioulac-Sage","year":"2010","unstructured":"Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban R, Theise ND, editors. WHO classification of tumours of the digestive system, 4th ed. Lyon: IARC Press; 2010. p. 198\u2013204.","edition":"4"},{"issue":"5","key":"8580_CR19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.onc.1209824","volume":"26","author":"J Zucman-Rossi","year":"2007","unstructured":"Zucman-Rossi J, Benhamouche S, Godard C, et al. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene. 2007;26(5):774\u201380.","journal-title":"Oncogene."},{"issue":"11","key":"8580_CR20","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/modpathol.2016.122","volume":"29","author":"G Hale","year":"2016","unstructured":"Hale G, Liu X, Hu J, et al. Correlation of exon 3 \u03b2-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol. 2016;29(11):1370\u201380.","journal-title":"Mod Pathol."},{"issue":"3","key":"8580_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","volume":"43","author":"J Zucman-Rossi","year":"2006","unstructured":"Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Hepatology. 2006;43(3):515\u201324.","journal-title":"Hepatology."},{"key":"8580_CR22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","volume":"25","author":"C Pilati","year":"2014","unstructured":"Pilati C, Letouze E, Nault JC, et al. Genomic profiling of hepatocellular adeonomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell. 2014;25:428\u201341.","journal-title":"Cancer Cell."},{"key":"8580_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouze E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505\u201311.","journal-title":"Nat Genet."},{"issue":"10","key":"8580_CR24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/bjs.5779","volume":"94","author":"JH Stoot","year":"2007","unstructured":"Stoot JH, van der Linden E, Terpstra OT, Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg. 2007;94(10):1249\u201353.","journal-title":"Br J Surg."},{"key":"8580_CR25","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386\u201398.","DOI":"10.1016\/j.jhep.2016.04.001"},{"issue":"3","key":"8580_CR26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1245\/s10434-008-0275-6","volume":"16","author":"JL Deneve","year":"2009","unstructured":"Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16(3):640\u20138.","journal-title":"Ann Surg Oncol."},{"key":"8580_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000052022","volume":"19","author":"P Marini","year":"2002","unstructured":"Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Dig Surg. 2002;19:109\u201313.","journal-title":"Dig Surg."},{"issue":"5","key":"8580_CR28","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2009.07.061","volume":"137","author":"S Dokmak","year":"2009","unstructured":"Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137(5):1698\u2013705.","journal-title":"Gastroenterology."},{"issue":"25","key":"8580_CR29","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.3748\/wjg.v23.i25.4579","volume":"23","author":"AJ Klompenhouwer","year":"2017","unstructured":"Klompenhouwer AJ, de Man RA, Thomeer MG, Ijzermans JN. Management and outcome of hepatocellular adenoma with massive bleeding at presentation. World J Gastroenterol. 2017;23(25):4579\u201386.","journal-title":"World J Gastroenterol."},{"issue":"7","key":"8580_CR30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/bjs.8762","volume":"99","author":"SM van Aalten","year":"2012","unstructured":"van Aalten SM, de Man RA, Ijzermans JN, et al. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99(7):911\u20136.","journal-title":"Br J Surg."},{"key":"8580_CR31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bmj.4.5995.496","volume":"29","author":"M Davis","year":"1975","unstructured":"Davis M, Portmann B, Searle M, et al. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J. 1975;29:496\u20138.","journal-title":"Br Med J."},{"issue":"1","key":"8580_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","volume":"60","author":"N Farges","year":"2011","unstructured":"Farges N, Ferrerira S, Dokmak J, et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2011;60(1):85\u20139.","journal-title":"Gut."},{"issue":"2","key":"8580_CR33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.11101742","volume":"262","author":"L Grazioli","year":"2012","unstructured":"Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520\u20139.","journal-title":"Radiology."},{"key":"8580_CR34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/1756283X16663882","volume":"9","author":"MG Thomeer","year":"2016","unstructured":"Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, et al. Hepatocellular adenoma: when and how to treat? Update of current evidence. Ther Adv Gastroenterol. 2016;9:898\u2013912.","journal-title":"Ther Adv Gastroenterol."},{"key":"8580_CR35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/radiol.2015142986","volume":"277","author":"MDF McInnes","year":"2015","unstructured":"McInnes MDF, Hibbert RM, Inacio JR, et al. Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid\u2013enhanced MR imaging\u2014a systematic review. Radiology. 2015;277:413\u201323.","journal-title":"Radiology."},{"issue":"4","key":"8580_CR36","doi-asserted-by":"crossref","first-page":"W408","DOI":"10.2214\/AJR.13.12251","volume":"203","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Fuentes-Orrego JM, Arnason T, et al. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2014;203(4):W408\u201314.","journal-title":"AJR Am J Roentgenol."},{"key":"8580_CR37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2013.114","volume":"27","author":"NM Joseph","year":"2014","unstructured":"Joseph NM, Ferrell LD, Jain D, et al. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol. 2014;27:62\u201372.","journal-title":"Mod Pathol."},{"issue":"4","key":"8580_CR38","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.24147","volume":"53","author":"M Ronot","year":"2011","unstructured":"Ronot M, Bahrami S, Calderaro J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53(4):1182\u201391.","journal-title":"Hepatology."},{"issue":"3","key":"8580_CR39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.22417","volume":"48","author":"H Laumonier","year":"2008","unstructured":"Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808\u201318.","journal-title":"Hepatology."},{"issue":"1","key":"8580_CR40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2010.10.030","volume":"55","author":"SM Van Aalten","year":"2011","unstructured":"Van Aalten SM, Verheij J, Terkivatan T, et al. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol. 2011;55(1):120\u20135.","journal-title":"J Hepatol."},{"key":"8580_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5152\/dir.2018.17525","volume":"25","author":"M Midia","year":"2019","unstructured":"Midia M, Devang O, Shuster A, et al. Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review. Diagn Interv Radiol. 2019;25:71\u201380.","journal-title":"Diagn Interv Radiol."},{"issue":"1","key":"8580_CR42","doi-asserted-by":"crossref","first-page":"HEP04","DOI":"10.2217\/hep-2017-0023","volume":"5","author":"A Vedie","year":"2018","unstructured":"Vedie A, Sutter O, Ziol M, et al. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepatol Oncol. 2018;5(1):HEP04.","journal-title":"Hepatol Oncol."},{"key":"8580_CR43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-105-4-547","volume":"105","author":"SC Gordon","year":"1986","unstructured":"Gordon SC, Reddy KR, Livingstone AS, et al. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med. 1986;105:547\u20139.","journal-title":"Ann Internal Med."},{"issue":"12","key":"8580_CR44","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/bjs.10594","volume":"104","author":"AJ Klompenhouwer","year":"2017","unstructured":"Klompenhouwer AJ, Br\u00f6ker MEE, Thomeer MGJ, et al. Retrospective study on timing of resection of hepatocellular adenoma. Br J Surg. 2017;104(12):1695\u2013703.","journal-title":"Br J Surg."},{"key":"8580_CR45","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/liv.12925","volume":"25","author":"S Dokmak","year":"2015","unstructured":"Dokmak S, Belghiti J. Will weight loss become a future treatment of hepatocellular adenoma in obese patients? Liver Int. 2015;25:2228\u201332.","journal-title":"Liver Int."},{"key":"8580_CR46","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1245\/s10434-008-0090-0","volume":"15","author":"SW Cho","year":"2008","unstructured":"Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"8580_CR47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/hpb.12069","volume":"15","author":"S Dokmak","year":"2013","unstructured":"Dokmak S, Samir F, Borscheid R, et al. 2012 Liver resections in the 21st century: we are far from zero mortality. HPB. 2013;15(11):908\u201315.","journal-title":"HPB."},{"key":"8580_CR48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/hpb.12257","volume":"16","author":"N de Angelis","year":"2014","unstructured":"de\u2019 Angelis N, Memo R, Calderaro J, et al. Open and laparoscopic resection of hepatocellular adenoma trends over 23 years at a specialist hepatobiliary unit. HPB. 2014;16:783\u20138.","journal-title":"HPB."},{"key":"8580_CR49","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1007\/s00464-017-5466-4","volume":"31","author":"F Landi","year":"2017","unstructured":"Landi F, de\u2019 Angelis N, Scatton O, et al. Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. Surg Endosc. 2017;31:4136.","journal-title":"Surg Endosc."},{"issue":"1","key":"8580_CR50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-018-6802-1","volume":"26","author":"JP Silva","year":"2019","unstructured":"Silva JP, Klooster B, Tsai S, et al. Elective regional therapy treatment for hepatic adenoma. Ann Surg Oncol. 2019;26(1):125\u201330.","journal-title":"Ann Surg Oncol."},{"key":"8580_CR51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jvir.2011.02.024","volume":"22","author":"MG van Vledder","year":"2011","unstructured":"van Vledder MG, van Aalten SM, Terkivatan T, et al. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol. 2011;22:787\u201393.","journal-title":"J Vasc Interv Radiol."},{"key":"8580_CR52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4292\/wjgpt.v7.i4.477","volume":"7","author":"A Facciorusso","year":"2016","unstructured":"Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: an updated review. Wold J Gastrointest Pharmacol Ther. 2016;7:477\u201389.","journal-title":"Wold J Gastrointest Pharmacol Ther."},{"key":"8580_CR53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/radiol.2422051411","volume":"242","author":"CL Brace","year":"2007","unstructured":"Brace CL, Laeseke PF, Sampson LA, et al. Microwave ablation with a single small-gauge triaxial antenna: in vivo porcine liver model. Radiology. 2007;242:435\u201340.","journal-title":"Radiology."},{"key":"8580_CR54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","volume":"12","author":"JH Soot","year":"2010","unstructured":"Soot JH, Coelen RJ, De Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxf). 2010;12:509\u201322.","journal-title":"HPB (Oxford)."},{"key":"8580_CR55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jvir.2015.09.021","volume":"27","author":"AR Smolock","year":"2016","unstructured":"Smolock AR, Cristescu MM, Potretzke TA, et al. Microwave ablation for the treatment of hepatic adenomas. J Vasc Interv Radiol. 2016;27:244\u20139.","journal-title":"J Vasc Interv Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08580-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:11:24Z","timestamp":1623712284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08580-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["8580"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08580-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}